Liver Cancer Diagnostics Market is expected to show an impressive CAGR of 6.7 % between 2021-28 according to the latest study published by Profshare Market Research. Rise in Liver cancer patients, Technological advancement, as well as enhanced research & development, are primary factors contributing to such a high growth rate in Liver Cancer Diagnostics Market.
In 2019 Global Liver Cancer Diagnostics Market was valued at around USD 9932.77 million & by the end of 2028 likely to reach USD 15194.78 million. Increasing demand along with the adoption of new techniques for diagnosis expected to help market recover fast in the post-pandemic period. Globally market has declined by almost 4.5 % in 2020 due to Covid 19 pandemic.
Adoption of new techniques in imaging tests, biomarkers can help to detect small tumors effectively. Peptides that are linked to dyes & attached to cancer cells can be observed using CT scan or MRI. This process helps to identify size, shape and location of tumors. Liver Cancer Diagnostics Market expected to generate lucrative opportunities during forecast period as many governments are encouraged to use these techniques, especially among high-risk populations.
The research study considers Imaging, Lab Tests, Endoscopy, Biopsy as primary screening types. Historical & Forecast revenue, volume & growth rate for each screening type is given in-detail. Lab Tests are heavily used Liver Cancer Diagnosis & hold around 30 % of market share in 2019. Endoscopy and Biopsy segments are likely to show an impressive growth rate between 2021 to 2028.
Application wise Liver Cancer Diagnostics Market is analyzed Hospitals, Physical Examination Centers, Cancer Research Institutes. Primarily due to increasing cases of Liver Cancer patients globally, Hospital segments are a major contributor to revenue of Liver Cancer Diagnostics Market. Physical Examination Centers has shown an impressive growth rate between 2015 to 2019 & likely to continue same growth rate between 2021 to 2028.
Access Full Report @ https://www.profsharemarketresearch.com/liver-cancer-diagnostics-market/
The report studied Liver Cancer Diagnostics Market for North America, Latin America, Europe, the Middle East, Asia Pacific, and Africa region. Regional outlook provides precise information regarding various market parameters. North America region leads the market & expected to continue dominance during forecast period. Technological advancement & high number of Liver Cancer patients propelling fuel to growth of Liver Cancer Diagnostics Market in the region.
Key players analysis helps to understand market share, positions & strategies of the manufacturers. Global Liver Cancer Diagnostics Market is highly moderately competitive though many new companies are emerging in the market. Companies are receiving high investments to improve the portfolio in the area of genomics and proteomics. Key players are identified through secondary research & further analysis use both primary & secondary market research model.
The research study includes the extensive use of primary and secondary data sources. Research process focuses on multiple factors affecting the industry such as competitive landscape, government policy, historical data, market current position, Liver Cancer Diagnostics Market trends, upcoming technologies & innovations as well as risks, rewards, opportunities and challenges. Study used top-down, bottom-up approach, SWOT analysis & supply-demand analysis models to get precise market information.
- Lab Tests
- Physical Examination Centers
- Cancer Research Institutes
The research report on Liver Cancer Diagnostics Market includes a competitive analysis that provides a better insight into the major companies of Liver Cancer Diagnostics. These major players include:
- Abbott Diagnostics
- AXO Science SAS
- BioMark Technologies
- Bioprognos SL
- Sky One Medic-a
- Digna Biotech SL
Related Market Research Report:
Cancer Diagnosis Devices Market by Product Type (Genimics, Proteoimics, Epigenetics)by Technology Type (Instrument-Based, Platform-Based Diagnostics, Tumor Biomarkers Tests) by Application (Cervical Cancer, Breast Cancer, Liver Cancer, Blood Cancer, Kidney Cancer, Colorectal Cancer, Pancreatic Cancer, Ovarian Cancer, Melanoma Lung Cancer) by Industry Analysis, Volume, Share, Growth, Challenges, Trends, and Forecast 2018-2026
Access the report @ https://www.profsharemarketresearch.com/cancer-diagnosis-devices-market-report/
Profshare Market Research is a full-service market research company that delivers in-depth market research globally. We operate within consumer and business-to-business markets offering both qualitative and quantitative research services. We work for private sector clients, along with public sector and voluntary organizations. Profshare Market Research publishes high quality, in-depth market research studies, to help clients obtain granular level clarity on current business trends and expected future developments. We are committed to our client’s needs, providing custom solutions best fit for strategy development and implementation to extract tangible results.
For more information visit @ https://www.profsharemarketresearch.com/